Categories
-Top News Bangladesh India News

Modi made us glorified with his presence: Hasina

Sheikh Hasina hailed Narendra Modi’s neighbourhood policy, saying that Bangladesh receiving 2 million Covid vaccine doses from India establishes this principle, reports Sumi Khan

Bangladesh Prime Minister Sheikh Hasina on Friday expressed her gratitude to her Indian counterpart Narendra Modi, saying the government of India always stands by Bangladesh through thick and thin.

Indian Prime Minister Narendra Modi arrived in Dhaka on Friday on a two-day visit to Bangladesh to attend the celebrations of the country’s 50th year of liberation from Pakistan and the 100th birth anniversary of its founder Sheikh Mujibur Rahman, the father of Sheikh Hasina.

“I’d like to express my heartfelt gratitude to Modi Ji and the people of India,” Hasina said.

Also Read – Modi begins Bangladesh tour with goodwill message

On the last day of the 10-day celebrations to mark the country’s 50th year of liberation from Pakistan, Modi and Hasina enjoyed the music of legendary classical vocalist Pandit Ajoy Chakravarty at the National Parade Square in Dhaka, along with the President of Bangladesh, Abdul Hamid, and others.

The Prime Minister, Narendra Modi being received by the Prime Minister of Bangladesh, Ms. Sheikh Hasina, on his arrival at Hazrat Shahjalal International Airport, in Dhaka, Bangladesh on March 26, 2021. (PIB)

Hasina said, “The Prime Minister of India made us glorified with his priceless presence in this pandemic period. The people of Bangladesh are grateful to Modi Ji and the people of India, who served the most for the people of Bangladesh in 1971.”

Hasina added that India must play a leading role in building a politically and economically prosperous South Asia. “We can make this region a hunger-free, poverty-free zone. We will achieve the goal set by the UN by 2031,” she said.

Also Read – B’desh sees violent anti-Modi protests

“I am grateful to India for nominating Bangabandhu Sheikh Mujibur Rahman for the prestigious Gandhi Peace Prize in 2019. India is our friendly neighbour, and the two countries share a long standing relationship. The government of India had provided all kinds of assistance to the people of Bangladesh who took refuge there to save their lives from the atrocity, rape and arson of the Pakistani army in 1971. The Indian government and its people gave shelter, served food and assured medical help to around 1 million helpless people from Bangladesh,” she said.

Prime Minister, Narendra Modi paying homage at the National Martyr’s Memorial, Savar, in Dhaka, Bangladesh on March 26, 2021.

“In 1971, many army officers from India shed their blood for the independence of Bangladesh. I respectfully remember their contributions. India’s cooperation will never be forgotten. I’m personally grateful to the people and government of India. After all my family members were killed during the war, I was at my husband’s workplace in Germany with my sister and children. I had lost everyone. There was no arrangement to stay in that country. At that time, then Prime Minister of India Indira Gandhi and Yugoslav leader Marshal Tito gave us shelter,” Hasina said.

Read More – Bangladesh thanks India for providing vaccines

The Bangladesh premier also appreciated the policies of Modi, and his slogan “Neighbours first and foremost”, saying that Bangladesh receiving 2 million Covid vaccine doses from India establishes this principle.

With the inauguration of the Maitri Bridge, India will now be able to use the Chittagong Port and Mongla Port, Hasina assured to Modi.

Prime Minister, Narendra Modi signing the visitor’s book at the National Martyr’s Memorial, Savar, in Dhaka, Bangladesh on March 26, 2021.

“May Bangladesh-India friendship be long-lasting for all kinds of cooperation,” she said.

Bangladesh President Abdul Hamid said, “During my stay in India for nine months during the liberation war in 1971, I myself witnessed how the government of India and its people gave shelter to 10 million people and refugees from Bangladesh. I hope all the unresolved issues will be settled soon. Bangladesh is always grateful to India.”

Categories
-Top News Asia News

Iran-Iraq border to be closed till April

On February 20, Iran closed several crossing points with Iraq to stem the spread of a new coronavirus variant…reports Asian Lite News.

While the coronavirus pandemic has continued to impact people of  all strata, as earlier borders are about to shut down. The border points between Iran and Iraq will be closed for passengers until April 4 in view of the ongoing Covid-19 pandemic, a top government official said here

The announcement was made on Wednesday by Hossein Qasemi, Director-General of Border Affairs of Iranian Interior Ministry, Xinhua news agency reported.

The decision was taken by the National Headquarters for Fighting Coronavirus following the request of the Ministry of Health and Medical Education, Qasemi told the media.

However, if there are Iranian nationals in Iraq who want to return, or if Iraqi nationals in Iran want to go back to their country, they can cross the border, he said.

Also, border crossing for traders, contractors and engineering activities would be possible after necessary evaluations, he added.

On February 20, Iran closed several crossing points with Iraq to stem the spread of a new coronavirus variant.

Also Read-No recent contact with US: Iran

Categories
-Top News COVID-19 EU News

EU revises vaccine export system

The principle of reciprocity will be applied to non-EU countries having at their disposal a large production capacity…reports Asian Lite News.

The European Commission presented a revised version of its export transparency mechanism for Covid-19 vaccines, with Executive Vice President Valdis Dombrovskis claiming that it does not constitute an export ban.

The mechanism takes aim at vaccines produced in European Union (EU)-based facilities of pharmaceutical companies that are bound by an advance purchase agreement (APA) with the EU. The new version includes two new criteria — reciprocity and proportionality — for assessing whether these vaccines can be exported to non-EU countries, according to Dombrovskis, Xinhua news agency reported on Wednesday.

The principle of reciprocity will be applied to non-EU countries having at their disposal a large production capacity. The European Commission and the EU member states will examine if the flow of imports and exports of vaccine and vaccine substances between the bloc and destination country is even.

Proportionality is about finding the right balance, the commissioner explained. The European Commission and the member states will take into account the specific situation of the country of destination, including its vaccination rate and the existing availability of Covid-19 vaccines.

AstraZeneca vaccine

Vaccine exports towards low- and middle-income countries covered by the COVAX (Covid-19 Vaccines Global Access) facility remain exempted.

Put in place on January 30, the export and transparency mechanism was launched when the EU argued that some pharmaceutical companies failed to honor their commitments to deliver the promised amount of doses to the EU countries but still could export vaccines from their EU-based facilities.

Originally due to expire on March 12, the mechanism has been extended until June 30.

(Photo: Pallav Paliwal)

A total of 381 export requests have been introduced by pharmaceutical companies bound by an APA with the EU, and only one has been declined.

AstraZeneca, a British-Swedish vaccine manufacturer, had applied to export 250,000 doses of its Covid-19 vaccine to Australia, while falling behind its delivery schedule for the EU.

“I remind you that AstraZeneca has only delivered a small portion of its agreed contractual commitments,” Dombrovskis said.

Also Read-EU leaders summit turns digital

Read More-EU sanctions China over Uighur abuses

Categories
-Top News COVID-19

‘Pfizer vax less potent against S. African variant’

For the study, the research team looked at the effectiveness of the vaccine against the original viral strain, the UK and the South African variants, as well as strains that harbour combined changes in the viral spike…reports Asian Lite News

The Pfizer-BioNTech Covid-19 vaccine is moderately less effective against the South African variant, suggests a study.

The findings, published in the journal Cell Host & Microbe, showed that the vaccine is effective against the original SARS-CoV-2 strain and the UK variant, but provides weakened protection against the South African variant and the combined UK-South African variants.

“Our findings show that future variants could necessitate a modified vaccine as the virus mutates to increase its infectivity,” said researcher Ran Taubea from the Ben-Gurion University of the Negev in Israel.

For the study, the research team looked at the effectiveness of the vaccine against the original viral strain, the UK and the South African variants, as well as strains that harbour combined changes in the viral spike.

They are continuing to test other circulating variants as they constantly emerge with the hope to identify potentially risky mutations that can compromise the vaccine, the study indicated.

The research team also compared neutralising antibody levels following administration of one and two doses of the vaccine, as opposed to levels in patients that have recovered from Covid-19.A

The team found that vaccination provided optimal levels of protection, when compared to the lower levels of protection that were observed in recovered patients.

A recent study, published in the journal Nature, also indicated that Covid-19 vaccines developed by Moderna and Pfizer-BioNTech significantly appear less effective against the Covid variant that first emerged in South Africa.
Also read:EU warns of vaccine export curbs

Categories
-Top News World News

Reimagining Diplomacy in the Post-COVID World: An Indian Perspective | Opinion

Real globalization is more about pandemics, climate change and terrorism. They must constitute the core of diplomatic deliberations. As we saw in 2020, overlooking such challenges comes at a huge cost…writes Dr. S. Jaishankar

We enter 2021, hoping to put the COVID-19 pandemic behind us. While each society has dealt with it uniquely, global diplomacy will nevertheless focus on common concerns and shared lessons. Much of that revolves around the nature of globalization.

Our generation has been conditioned to think of that largely in economic terms. The general sense is one of trade, finance, services, communication, technology and mobility. This expresses the interdependence and interpenetration of our era. What COVID, however, brought out was the deeper indivisibility of our existence.

Indian Student activists carry posters and shout slogans as they participate in a protest march against climate change, in New Delhi on India, 19 March, 2021 (Pallav Paliwal)

Real globalization is more about pandemics, climate change and terrorism. They must constitute the core of diplomatic deliberations. As we saw in 2020, overlooking such challenges comes at a huge cost.

Despite its many benefits, the world has also seen strong reactions to globalization. Much of that arises from unequal benefits, between and within societies. Regimes and dispensations that are oblivious to such happenings are therefore being challenged. We must ensure that this is not about winners and losers, but about nurturing sustainable communities everywhere.

A police officer receives the COVID-19 vaccination at a police hospital.

COVID-19 has also redefined our understanding of security. Until now, nations thought largely in military, intelligence, economic, and perhaps, cultural terms. Today, they will not only assign greater weight to health security but increasingly worry about trusted and resilient supply chains. The stresses of the COVID-19 era brought out the fragility of our current situation. Additional engines of growth are needed to de-risk the global economy, as indeed is more transparency and market-viability.

Multilateral institutions have not come out well from this experience. Quite apart from controversies surrounding them, there was not even a pretense of a collective response to the most serious global crisis since 1945. This is cause for serious introspection. Reforming multilateralism is essential to creating effective solutions.

Fashioning a robust response to the COVID-19 challenge is set to dominate global diplomacy in 2021. In its own way, India has set an example. That it has done by defying prophets of doom and creating the health wherewithal to minimize its fatality rate and maximize its recovery rate. An international comparison of these numbers tells its own story. Not just that, India also stepped forward as the pharmacy of the world, supplying medicines to more than 150 countries, many as grants.

As our nation embarks on a mass vaccination effort, Prime Minister Narendra Modi’s assurance that it would help make vaccines accessible and affordable to the world is already being implemented. The first consignments of Made in India vaccines have reached not only our neighbors like Bhutan, Maldives, Bangladesh, Nepal, Mauritius, Seychelles and Sri Lanka but partners far beyond like Brazil and Morocco.

Other key global challenges today deserve similar attention. As a central participant in reaching the Paris agreement, India has stood firm with regard to combating climate change. Its renewable energy targets have multiplied, its forest cover has grown, its bio-diversity has expanded and its focus on water utilization has increased. Practices honed at home are now applied to its development partnerships in Africa and elsewhere. By example and energy, Indian diplomacy is leading the way, including through the International Solar Alliance and the Coalition for Disaster Resilient Infrastructure initiatives.

The challenge of countering terrorism and radicalization is also a formidable one. As a society, long subjected to cross-border terrorist attacks, India has been active in enhancing global awareness and encouraging coordinated action. It will be a major focus in India’s diplomacy as a non-permanent member of the Security Council and in forums like FATF and G20.

Among the takeaways from the COVID-19 experience has been the power of the digital domain. Whether it was contact tracing or the provision of financial and food support, India’s digital focus after 2014 has yielded impressive results. The “work from anywhere” practice was as strongly enhanced by COVID-19 as the “study from home” one. All these will help expand the toolkit of India’s development programs abroad and assist the recovery of many partners.

2020 also saw the largest repatriation exercise in history–the return home of more than 4 million Indians. This alone brings out the importance of mobility in contemporary times. As smart manufacturing and the knowledge economy take deeper root, the need for trusted talent will surely grow. Facilitating its movement through diplomacy is in the global interest.

A return to normalcy in 2021 will mean safer travel, better health, economic revival and digitally driven services. They will be expressed in new conversations and fresh understandings. The world after COVID-19 will be more multi-polar, pluralistic and rebalanced. And India, with its experiences, will help make a difference.

(Dr. S. Jaishankar is the Minister of External Affairs of India and author of “The India Way: Strategies for an Uncertain World.” The views expressed in this article are the writer’s own.)

Also Read-Jaishankar, Pompeo discuss COVID-19 developments

Read More-Will raise Oxford University racism issue when required: Jaishankar

Categories
-Top News USA

Covid mutant cases in US at 6,000

Majority of these cases were caused by the variant known as B.1.1.7, which was originally detected in Britain…reports Asian Lite News

Over 6,000 infection cases of coronavirus variants have been reported in the United States, according to the latest data of the US Centers for Disease Control and Prevention (CDC).

The vast majority of these cases, 6,390, were caused by the variant known as B.1.1.7, which was originally detected in Britain, Xinhua news agency reported.

There were 194 cases of a new strain initially discovered in South Africa, called B.1.351, and 54 cases of the P.1 strain first discovered in Brazil.

In addition, the B.1.427 and B.1.429 variants, two coronavirus strains first detected in California, are also being closely monitored by the CDC.

children walking in street during covid 19 surge in us

The five coronavirus strains are currently classified by the CDC as “variants of concern,” as evidence shows an increase in their transmissibility, increased hospitalizations or deaths, significant reduction in neutralization by antibodies generated during previous infection or vaccination, reduced effectiveness of treatments or vaccines, or diagnostic detection failures.

The CDC and its partners are increasing the numbers of specimens sequenced in laboratories around the country, according to the agency.

People wearing face masks visit the Lincoln Memorial Reflecting Pool in Washington, D.C during covid 19 surge

Viruses constantly change through mutation. Currently, multiple variants of SARS-CoV-2 have been documented in the United States and globally.

Public health officials said protective measures like mask use, physical distancing, hand hygiene and prompt vaccination can help prevent against Covid-19 infections and emerging strains.

Also read:Russia’s US envoy returns to Moscow

Categories
-Top News China Sri Lanka

Chinese pressure? Lanka approves Sinopharm

It seems that Sri Lanka was under alleged Chinese pressure to approve its Sinopharm vaccine as part of countering India’s growing vaccine outreach to neighbouring countries, reports Asian Lite News

Sri Lanka’s National Medicines Regulatory Authority (NMRA) on Saturday approved China’s Sinopharm Covid-19 vaccine for emergency use in the island country.

According to State Minister of Production, Supply and Regulation of Pharmaceuticals Channa Jayasumana, this is the third Covid-19 vaccine to be approved in the country after the AstraZeneca and Russia’s Sputnik V jabs, reports Xinhua news agency.

Also Read – Sri Lanka falling deep to China’s googly

Earlier this month, General Manager of the State Pharmaceutical Corporation (SPC) Dinusha Dassanayake said the SPC had also made an application to the NMRA to clear China’s Sinovac vaccine for emergency use.

Last month, a Sri Lankan government spokesman had confirmed that it had put Chinese Sinopharm’s Covid-19 vaccine on hold and would use India-manufactured Oxford AstraZeneca vaccine to inoculate 14 million people.

According to reports, the Chinese embassy in Colombo has been placing stress on political management since January and making public statements that their vaccine will arrive by mid-Feb and regulatory approval can even be obtained by then.

A police officer receives the COVID-19 vaccination at a police hospital in Colombo, Sri Lanka. (Photo: Ajith Perera/Xinhua/ians)

Sri Lanka is in the midst of a mass inoculation program as it began inoculating all those above 30 years old in the urban Western Province from mid-February, after vaccinating frontline workers and health workers with the AstraZeneca doses.

Sri Lanka received AstraZeneca doses from India in January and February.

It also received 264,000 doses of the AstraZeneca vaccine under the World Health Organization-led COVAX facility which is being administered to those above the age of 60 years.

Also Read – Sri Lanka to continue AstraZeneca jabs

Last month, Sri Lankan President Gotabaya Rajapaksa thanked India for its generosity after he obtained 500,000 doses of Covishield vaccine donated by the nation below the ‘Neighbourhood First’ coverage.

Last week, Narendra Modi and Gotabaya Rajapaksa had agreed to maintain regular contact between relevant officials, including in the context of the continuing Covid-19 challenges.

Sri Lanka expects India’s backing at UNHRC

Sri Lankan Foreign Secretary Jayanath Colombage has confirmed that India has assured Sri Lanka of its support at the United Nations Human Rights Council (UNHRC).

The UNHRC member countries will vote on a new resolution on the Sri Lanka’s rights and accountability record on March 22.

Sri Lankan President Gotabaya Rajapaksa and Indian Prime Minister Narendra Modi

“Being the superpower they are, Sri Lanka greatly appreciates their position,” the state-run Daily News quoted the foreign secretary’s remarks, who was speaking at the Third Digital Dialogue hosted by the Media Centre for National Development.

Colombage had earlier sent an official communique to Prime Minister Narendra Modi seeking India’s support when Sri Lanka’s record in human rights and related accountability will be probed in the Geneva-based body.

UK, Germany, Canada, Malawi, North Macedonia and Montenegro are the members of the Sri Lanka Core Group.

Also Read – Imran pitches CPEC to Lanka

“The Core Group restates the ongoing importance of addressing Sri Lanka in the Human rights Council. Informed by the report the core group intends to present a resolution to promote reconciliation accountability and human rights in Sri Lanka,” the statement read.

According to The Hindu, Colombo has also been reaching out to member countries during the past weeks, pitching its version of Sri Lanka’s post-war realities that the U.N. resolutions seek to address.

President Gotabaya Rajapaksa wrote to Prime Minister Narendra Modi, among other leaders, including Chinese President Xi Jinping, seeking support at the 47-member Council where Colombo anticipates a hostile resolution.

All eyes are on India’s vote, not only because of its “influence” in the Council, but also because of its own tensions with Colombo, following the Rajapaksa government’s recent decisions on strategic projects involving India and China, according to the report.

Given India’s pressing geopolitical concerns in the island nation, and stated support for Tamil aspirations, it remains to be seen how India will approach on the vote.

Categories
-Top News COVID-19 EU News

WHO warns against easing curbs too early

Many European countries are currently reinforcing lockdown

Kluge’s warning on Thursday came as the region has been witnessing a rise in Covid-19 transmission rates, while its death toll was inching towards the 1 million mark…reports Asian Lite News

Hans Kluge, the World Health Organization’s (WHO) Regional Director for Europe, has warned countries against premature easing of Covid-19 restrictions.

Kluge’s warning on Thursday came as the region has been witnessing a rise in Covid-19 transmission rates, while its death toll was inching towards the 1 million mark, Xinhua news agency.

Addressing a virtual press conference here, Kluge noted that “while 27 countries are currently in a partial or full nationwide lockdown, 21 are gradually easing restrictive measures”.

“Some are doing so based on the assumption that increasing vaccination uptake in countries would immediately lead to an improved epidemiological situation,” he said.

“Such assumptions are too early to make.”

Kluge stressed that with vaccination coverage in the region ranging from less than 1 per cent to 44 per cent, it is “far too early to demonstrate the effect of vaccines on overall Covid-19 hospitalisation and deaths”.

Despite “giant scientific leaps and the introduction of effective tools that give us power over the virus”, the WHO official acknowledged that in parts of the region, such as central Europe, the Balkans and the Baltic states, “case incidence, hospitalizations and deaths are now among the highest in the world”.

According to Kluge, case incidence in Europe continues its increasing trend, with over 1.2 million new cases reported last week.

“Last week, new deaths in the region surpassed 900,000. Every week, more than 20,000 people across the region lose their lives to the virus,” said Kluge.

“The number of people dying from Covid-19 in Europe is higher now than it was this time last year, reflecting the widespread hold this virus has.”

As a consequence of the rising numbers, the regional director called upon states in the region to “remain steadfast in our application of the full range of tools” to fight the coronavirus.

“Let there be no doubt about it, vaccination by itself, particularly given the varied uptake in countries, does not replace public health and social measures,” said Kluge.

Also read:WHO warns of ‘post Covid’ health risks

Categories
-Top News EU News

European nations to resume AstraZeneca jabs

The EMA has ruled out claims of blood clots

France, Italy, Latvia and Bulgaria announced they would likely restart vaccinations using the AstraZeneca jab on Friday following the EMA advice….reports Asian Lite News

Several European countries have announced they would restart vaccinations with the AstraZeneca Covid-19 jab after the European Medicines Agency (EMA) deemed it “safe and effective”.

The EMA statement came after an extensive review of possible blood clot risks, the agency’s chief said on Thursday, following reports that some people had developed blood clots in the period after having the injection, reports dpa news agency.

France, Italy, Latvia and Bulgaria announced they would likely restart vaccinations using the AstraZeneca jab on Friday following the EMA advice.

Spain would reportedly follow suit next week, according to El Pais newspaper.

In an effort to bolster damaged public confidence in the vaccine, French Premier Jean Castex announced that he himself would receive the injection on Friday.

Swedish health authorities said, on the other hand, that they would need “a few days” to assess the EMA report before lifting the ban on AstraZeneca.

“The suspension remains for the time being,” Johan Carlson, head of the Swedish Public Health Agency, told reporters.

Also read:EU’s ‘Green Certificate’ for safe travel

Germany will aim to restart vaccinations using AstraZeneca’s vaccine on Friday, Health Minister Jens Spahn said.

The restart in Germany would come with new advice on the vaccine’s side effects, Spahn added.

Blood clot reports from several countries prompted governments around the world to halt inoculations with the AstraZeneca jab.

This slowed down already sluggish inoculation campaigns in the European Union.

The EMA, which had approved the jab in January, launched a review of the risks.

“The committee has come to a clear scientific conclusion,” the agency’s chief Emer Cooke said when presenting the findings.

“This is a safe and effective vaccine. Its benefits in protecting people from Covid-19, with the associated risks of death and hospitalisation, outweigh the possible risks,” Cooke said.

A woman receives a COVID-19 vaccine during a vaccination campaign for healthcare professionals in Nice

The agency’s committee concluded that the vaccine was not associated with an increase in the overall risk of thromboembolic events or blood clots.

“When you vaccinate millions of people, it’s invevitable that rare or serious incidences or illnesses will occur in the time immediately following vaccination,” she said.

However, the agency could not definitively rule out a link between cases of rare, very serious clotting disorders and the vaccine, and said it launched additional investigations to understand the issue.

The EMA therefore recommended issuing warnings by including the risks in the product information.

The World Health Organization has also recommended the continued use of the vaccine.

Also read:EU warns of vaccine export curbs

Categories
-Top News EU News

EU warns of vaccine export curbs

Several European Union (EU) nations have already called for a debate on the distribution of Covid-19 vaccines in the bloc.

The EU is facing a third wave of the coronavirus pandemic, and at present less than a tenth of its population is vaccinated….reports Asian Lite News

European Commission President Ursula von der Leyen has warned that the European Union (EU) might restrict vaccine exports to countries who have higher inoculation rates, stressing the necessity to ensure reciprocity and proportionality of the vaccine exports.

“We are in the crisis of the century, and I’m not ruling out anything for now, because we have to make sure that Europeans are vaccinated as soon as possible,” she told a press conferenceon Wednesday.

The EU is facing a third wave of the coronavirus pandemic, and at present less than a tenth of its population is vaccinated.

Doris Wildgoose, 99, receives her second dose of the Pfizer-BioNTech COVID-19 vaccine at Hyde Leisure Centre in Greater Manchester, Britain, on Jan. 7, 2021. (Photo by Jon Super/Xinhua/ians)



Around 41 million doses of vaccines have been exported from EU to 33 countries and regions since February 1, von der Leyen said, while accusing the British multinational pharmaceutical company AstraZeneca of having “underproduced and underdelivered” to the bloc, with the original 180 million doses dwindling down to just 70 million.

Row with AstraZeneca

The Commission chief has been under pressure over the EU’s handling of the bloc’s vaccination rollout, with Brussels engaging in a row with AstraZeneca over vaccine deliveries.

The dispute escalated with the EU at one point threatening to override the Brexit agreement with the UK over the Irish border, which came after AstraZeneca had said the initial number of doses it could supply to the EU would be lower than first thought.

“If the situation does not change, we will have to reflect on how to make exports to vaccine-producing countries dependent on their level of openness,” said von der Leyen.

Besides, the EU will also reflect on whether exports to countries who have higher vaccination rates are still proportionate, she added.

Furthermore, she warned that the EU is ready to use whatever tool needed to ensure “Europe gets its fair share”.

Also read:EU’s ‘Green Certificate’ for safe travel